Betekenis van:
oestradiol
oestradiol
Zelfstandig naamwoord
- the most powerful female hormone that occurs naturally; synthesized and used to treat estrogen deficiency and breast cancer
Synoniemen
Hyperoniemen
Voorbeeldzinnen
- 17β-Oestradiol
- NO ENTRY 17β-Oestradiol
- 17β-Oestradiol NOT APPLICABLE
- Oestradiol 17β and its ester-like derivatives.
- No MRL required for all tissues except milk NOT APPLICABLE NO ENTRY 17β-Oestradiol
- A temporary exemption was provided for the use of oestradiol 17β for oestrus induction in cattle, horses, sheep or goats until 14 October 2006.
- That Report concludes that oestradiol 17β is not essential in the production of food-producing animals because the use of the available alternatives (especially prostaglandins) by practising veterinarians is already quite common in the Member States and that the complete prohibition of the use of oestradiol 17β for food-producing animals would have no, or only a negligible, impact on farming and animal welfare.
- Article 11a of Directive 96/22/EC required the Commission to present a report by 14 October 2005 concerning the availability of alternative veterinary medicinal products to those containing oestradiol 17β for food-producing animals for therapeutic purposes.
- The Commission sought expert advice and established the relevant scientific report, which was forwarded to the European Parliament and the Council on 11 October 2005. That Report concludes that oestradiol 17β is not essential in the production of food-producing animals because the use of the available alternatives (especially prostaglandins) by practising veterinarians is already quite common in the Member States and that the complete prohibition of the use of oestradiol 17β for food-producing animals would have no, or only a negligible, impact on farming and animal welfare.
- A temporary exemption was provided for the use of oestradiol 17β for oestrus induction in cattle, horses, sheep or goats until 14 October 2006. Since effective alternative products exist and are already used, and in order to ensure the high level of health protection chosen in the Community, that exemption should not be renewed.
- For therapeutic and zootechnical purposes only. Agents acting on the reproductive system Novobiocin Novobiocin Bovine 50 μg/kg Milk For intramammary use only. Anti-infectious agents/Antibiotics NOT APPLICABLE Bovine No MRL required for all tissues except milk NOT APPLICABLE NO ENTRY 17β-Oestradiol NOT APPLICABLE All mammalian food producing species No MRL required NOT APPLICABLE For therapeutic and zootechnical use only. NO ENTRY Okoubaka aubrevillei NOT APPLICABLE All food producing species No MRL required
- The Commission, in collaboration with the Member States, shall set up an information and awareness campaign on the complete ban on the use of oestradiol 17β in food-producing animals, aimed at farmers and veterinary organisations in the EU as well as the relevant organisations outside the EU which are directly or indirectly involved in the export to the EU of food of animal origin falling within the scope of this Directive.’.
- As a result, Directive 96/22/EC was amended by Directive 2003/74/EC so as to, inter alia, prohibit permanently the use of oestradiol 17β as a growth promoter and reduce substantively all other circumstances in which it can be administered to all farm animals for therapeutic or zootechnical purposes pending further examination of the factual and scientific situation and the veterinary practices in the Member States.
- The Opinion of the Scientific Committee on Veterinary Measures relating to Public Health (SCVPH) of 30 April 1999 on the potential risks to human health from hormone residues in bovine meat and meat products (which was reviewed on 3 May 2000 and confirmed on 10 April 2002) concluded that there is a substantial body of recent evidence suggesting that oestradiol 17ß has to be considered as a complete carcinogen, as it exerts both tumour-initiating and tumour-promoting effects, and that the data currently available do not make it possible to give a quantitative estimate of the risk to human health.